e-learning
resources
Vienna 2003
Monday 29.09.2003
Cigarette smoke: how it does its dirty work
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An inhaled MMP inhibitor blocks cigarette-induced lung damage in the smoking mouse model
P. A. Pemberton, J. S. Cantwell, K. M. Kim, D. J. Sundin, D. Kobayashi, J. Fink, S. D. Shapiro, P. J. Barr (Alameda, St. Louis, Mountain View, Boston)
Source:
Annual Congress 2003 - Cigarette smoke: how it does its dirty work
Session:
Cigarette smoke: how it does its dirty work
Session type:
Oral Presentation
Number:
1317
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. A. Pemberton, J. S. Cantwell, K. M. Kim, D. J. Sundin, D. Kobayashi, J. Fink, S. D. Shapiro, P. J. Barr (Alameda, St. Louis, Mountain View, Boston). An inhaled MMP inhibitor blocks cigarette-induced lung damage in the smoking mouse model. Eur Respir J 2003; 22: Suppl. 45, 1317
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
PDE4 inhibition prevents corticosteroid-resistant lung inflammation induced by cigarette smoke exposure in mice
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009
A neutrophil elastase inhibitor reduces cigarette smoke-induced remodelling of lung vessels
Source: Eur Respir J 2003; 22: 77-81
Year: 2003
Mitochondria-targeted H2S suppresses and reverses cigarette smoke-induced inflammasome activity and lung injury in experimental COPD
Source: ERS Lung Science Conference 2020
Year: 2020
Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice
Source: Eur Respir J 2006; 27: 1102-1109
Year: 2006
Potent anti-inflammatory effects of the highly selective iNOS inhibitor Byk402750 in a mouse model of cigarette smoke induced inflammation
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008
Inhaled recombinant alpha 1-antitrypsin ameliorates cigarette-induced lung damage in the smoking mouse model
Source: Annual Congress 2004 - Insights into asthma and COPD
Year: 2004
P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
LPS accelerates cigarette smoke-induced deterioration in respiratory function and airway inflammation in mice
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
Cigarette smoke-induced emphysema occurs in the absence of TLR4-signalling in a murine model of COPD
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008
Tiotropium inhalation prevents acute cigarette smoke-induced airway inflammation in mice
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009
Ceramide-1-phosphate inhibits cigarette smoke-induced airway inflammation
Source: Eur Respir J 2015; 45: 1669-1680
Year: 2015
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Source: Eur Respir J 2014; 43: 1211-1212
Year: 2014
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Source: Eur Respir J 2014; 43: 1208-1211
Year: 2014
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Source: Eur Respir J 2013; 42: 350-361
Year: 2013
Therapeutic neutralization of the matrikine PGP suppresses the development of lung emphysema in cigarette smoke exposed mice
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Oral presentation: SOD3 protects cigarette smoke-induced emphysema associated with reduction of extracellular matrix fragmentation in mice
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
Lack of poly(ADP-ribose) polymerase-1 does not affect acute lung injury but induces excessive lung remodelling after hyperoxia exposure
Source: Annual Congress 2005 - Highlights of the 2005 ERS Lung Science Conference in Taormina
Year: 2005
Effect of substance 101333-3 on emphysema and MMP activity in a model of cadmium-induced emphysema
Source: Eur Respir J 2005; 26: Suppl. 49, 579s
Year: 2005
Aclidinium inhibits cigarette smoke-induced lung fibroblast-to-myofibroblast transition
Source: Eur Respir J 2013; 41: 1264-1274
Year: 2013
The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept